Combining artificial intelligence technology with MRI brain scans, researchers are able to detect the brain's response to Natalizumab treatment for those with relapsing-remitting multiple sclerosis.
from Neuroscience News Updates http://bit.ly/2IcBLw2
from Neuroscience News Updates http://bit.ly/2IcBLw2
Comments
Post a Comment